Effects of Telehealth on Dropout and Retention in Care among Treatment-Seeking Individuals with Substance Use Disorder: A Retrospective Cohort Study

References

• Ahmad, F. B., Rossen, L. M., & Sutton, P. (2021). Provisional drug overdose death counts. National Center for Health Statistics. Retrieved January 4, 2022, from https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.
   Google Scholar
• American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., Text rev.). American Psychiatric Association.
   Google Scholar
• Armour, S., & Whelan, R. (2021, November 22). Telehealth rollbacks leave patients stranded, some doctors say. Wall Street Journal. https://www.wsj.com/articles/telehealth-rollbacks-leave-patients-stranded-some-doctors-say-11637577001
   Google Scholar
• Cacciola, J. S., Alterman, A. I., Dephilippis, D., Drapkin, M. L., Valadez, C., Jr., Fala, N. C., Oslin, D., & McKay, J. R. (2013). Development and initial evaluation of the Brief Addiction Monitor (BAM). Journal of Substance Abuse Treatment, 44(3), 256–263. https://doi.org/10.1016/j.jsat.2012.07.013
   PubMed Web of Science ®Google Scholar
• Campos-Castillo, C., & Anthony, D. (2021). Racial and ethnic differences in self-reported telehealth use during the COVID-19 pandemic: A secondary analysis of a US survey of internet users from late March. Journal of the American Medical Informatics Association: JAMIA, 28(1), 119–125. https://doi.org/10.1093/jamia/ocaa221
   PubMed Web of Science ®Google Scholar
• Chunara, R., Zhao, Y., Chen, J., Lawrence, K., Testa, P. A., Nov, O., & Mann, D. M. (2021). Telemedicine and healthcare disparities: A cohort study in a large healthcare system in New York City during COVID-19. Journal of the American Medical Informatics Association, 28(1), 33–41. https://doi.org/10.1093/jamia/ocaa217
   PubMed Web of Science ®Google Scholar
• Collins, K. M., Armenta, R. F., Cuevas-Mota, J., Liu, L., Strathdee, S. A., & Garfein, R. S. (2016). Factors associated with patterns of mobile technology use among persons who inject drugs. Substance Abuse, 37(4), 606–612. https://doi.org/10.1080/08897077.2016.1176980
   PubMed Web of Science ®Google Scholar
• Czeisler, M. É., Lane, R. I., Wiley, J. F., Czeisler, C. A., Howard, M. E., & Rajaratnam, S. (2021). Follow-up survey of US adult reports of mental health, substance use, and suicidal ideation during the COVID-19 pandemic, September 2020. JAMA Network Open, 4(2), e2037665. https://doi.org/10.1001/jamanetworkopen.2020.37665
   PubMed Web of Science ®Google Scholar
• Early, J., & Hernandez, A. (2021). Digital disenfranchisement and COVID-19: Broadband internet access as a social determinant of health. Health Promotion Practice, 22(5), 605–610. https://doi.org/10.1177/15248399211014490
   PubMed Web of Science ®Google Scholar
• Eibl, J. K., Gauthier, G., Pellegrini, D., Daiter, J., Varenbut, M., Hogenbirk, J. C., & Marsh, D. C. (2017). The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting. Drug and Alcohol Dependence, 176, 133–138. https://doi.org/10.1016/j.drugalcdep.2017.01.048
   PubMed Web of Science ®Google Scholar
• Farhoudian, A., Baldacchino, A., Clark, N., Gerra, G., Ekhtiari, H., Dom, G., Mokri, A., Sadeghi, M., Nematollahi, P., Demasi, M., Schütz, C. G., Hash-Emian, S. M., Tabarsi, P., Galea-Singer, S., Carrà, G., Clausen, T., Kouimtsidis, C., Tolomeo, S., Radfar, S. R., & Razaghi, E. M. (2020). COVID-19 and substance SSE disorders: Recommendations to a comprehensive healthcare response. An international society of addiction medicine practice and policy interest group position paper. Basic and Clinical Neuroscience, 11(2), 133–150. https://doi.org/10.32598/bcn.11.covid19.1
   PubMed Web of Science ®Google Scholar
• Fishman, M., Vo, H. T., Burgower, R., Ruggiero, M., Rotrosen, J., Lee, J., & Nunes, E. (2020). Treatment trajectories during and after a medication trial for opioid use disorder: Moving from research as usual to treatment as usual. Journal of Addiction Medicine, 14(4), 331–336. https://doi.org/10.1097/ADM.0000000000000592
   PubMed Web of Science ®Google Scholar
• Hare, N., Bansal, P., Bajowala, S. S., Abramson, S. L., Chervinskiy, S., Corriel, R., Hauswirth, D. W., Kakumanu, S., Mehta, R., Rashid, Q., Rupp, M. R., Shih, J., & Mosnaim, G. S. (2020). Work group report: COVID-19: Unmasking telemedicine. The Journal of Allergy and Clinical Immunology. In Practice, 8(8), 2461–2473.e3. https://doi.org/10.1016/j.jaip.2020.06.038
   PubMed Web of Science ®Google Scholar
• Harris, A. H., Humphreys, K., Bowe, T., Tiet, Q., & Finney, J. W. (2010). Does meeting the HEDIS substance abuse treatment engagement criterion predict patient outcomes? The Journal of Behavioral Health Services & Research, 37(1), 25–39. https://doi.org/10.1007/s11414-008-9142-2
   PubMed Web of Science ®Google Scholar
• Health Resources & Services Administration. (2021, December 14). What is telehealth? https://www.hrsa.gov/rural-health/telehealth/what-is-telehealth
   Google Scholar
• Jones, C. M., Shoff, C., Hodges, K., Blanco, C., Losby, J. L., Ling, S. M., & Compton, W. M. (2022). Receipt of telehealth services, receipt and retention of medications for opioid use disorder, and medically treated overdose among medicare beneficiaries before and during the COVID-19 pandemic. JAMA Psychiatry, 79(10), 981. https://doi.org/10.1001/jamapsychiatry.2022.2284
   PubMed Web of Science ®Google Scholar
• Koonin, L., Hoots, B., Tsang, C., Leroy, Z., Farris, K., Jolly, T., Antall, P., McCabe, B., Zels, C., Tong, I., & Harris, A. (2020). Trends in the use of telehealth during the emergence of the COVID-19 pandemic—United States, January–March 2020. MMWR - Morbidity and Mortality Weekly Report, 2020(69), 1595–1599. https://doi.org/10.15585/mmwr.mm6943a3
   Google Scholar
• Langabeer, J. R., II, Yatsco, A., & Champagne-Langabeer, T. (2021). Telehealth sustains patient engagement in OUD treatment during COVID-19. Journal of Substance Abuse Treatment, 122, 108215. https://doi.org/10.1016/j.jsat.2020.108215
   PubMed Web of Science ®Google Scholar
• Lin, L. A., Casteel, D., Shigekawa, E., Weyrich, M. S., Roby, D. H., & McMenamin, S. B. (2019). Telemedicine-delivered treatment interventions for substance use disorders: A systematic review. Journal of Substance Abuse Treatment, 101, 38–49. https://doi.org/10.1016/j.jsat.2019.03.007
   PubMed Web of Science ®Google Scholar
• Lin, L. A., Zhang, L., Kim, H. M., & Frost, M. C. (2022). Impact of COVID-19 telehealth policy changes on buprenorphine treatment for opioid use disorder. American Journal of Psychiatry, 179(10), 740–747. https://doi.org/10.1176/appi.ajp.21111141
   PubMed Web of Science ®Google Scholar
• Lott, A., Campbell, K. A., Hutzler, L., & Lajam, C. M. (2022). Telemedicine utilization at an academic medical center during COVID-19 pandemic: Are some patients being left behind? Telemedicine Journal and e-Health, 28(1), 44–50. https://doi.org/10.1089/tmj.2020.0561
   PubMed Web of Science ®Google Scholar
• Madras, B. K., Ahmad, N. J., Wen, J., & Sharfstein, J., The Prevention, Treatment, and Recovery Working Group of the Action Collaborative on Countering the U.S. Opioid Epidemic. (2020). Improving access to evidence-based medical treatment for opioid use disorder: Strategies to address key barriers within the treatment system. NAM Perspectives. Discussion Paper. https://doi.org/10.31478/202004b
   Google Scholar
• Mark, T. L., Treiman, K., Padwa, H., Henretty, K., Tzeng, J., & Gilbert, M. (2022). Addiction treatment and telehealth: Review of efficacy and provider insights during the COVID-19 pandemic. Psychiatric Services, 73(5), 484–491. https://doi.org/10.1176/appi.ps.202100088
   Google Scholar
• Molfenter, T., Roget, N., Chaple, M., Behlman, S., Cody, O., Hartzler, B., Johnson, E., Nichols, M., Stilen, P., & Becker, S. (2021). Use of telehealth in substance use disorder services during and after COVID-19: Online survey study. JMIR Mental Health, 8(2), e25835. https://doi.org/10.2196/25835
   PubMed Web of Science ®Google Scholar
• Naeger, S., Mutter, R., Ali, M. M., Mark, T., & Hughey, L. (2016). Post-discharge treatment engagement among patients with an opioid-use disorder. Journal of Substance Abuse Treatment, 69, 64–71. https://doi.org/10.1016/j.jsat.2016.07.004
   PubMed Web of Science ®Google Scholar
• National Committee for Quality Assurance. (2022, January 4). Initiation and engagement of alcohol and other drug abuse or dependence treatment (IET). https://www.ncqa.org/hedis/measures/initiation-and-engagement-of-alcohol-and-other-drug-abuse-or-dependence-treatment/
   Google Scholar
• National Institute on Drug Abuse (NIDA). (2020). Principles of effective treatment. https://nida.nih.gov/publications/principles-drug-addiction-treatment-research-based-guide-third-edition/principles-effective-treatment
   Google Scholar
• O’Brien, M., & McNicholas, F. (2020). The use of telepsychiatry during COVID-19 and beyond. Irish Journal of Psychological Medicine, 37(4), 250–255. https://doi.org/10.1017/ipm.2020.54
   PubMed Web of Science ®Google Scholar
• Perri, M., Guta, A., Gagnon, M., Bonn, M., Leece, P., Bayoumi, A. M., Rai, N., Touesnard, N., & Strike, C. (2021). Developing a digital health strategy for people who use drugs: Lessons from COVID-19. Digital Health, 7, 20552076211028404. https://doi.org/10.1177/20552076211028404
   Web of Science ®Google Scholar
• Perry, B. L., Aronson, B., & Pescosolido, B. A. (2021). Pandemic precarity: COVID-19 is exposing and exacerbating inequalities in the American heartland. Proceedings of the National Academy of Sciences, 118(8), e2020685118. https://doi.org/10.1073/pnas.2020685118
   PubMed Web of Science ®Google Scholar
• Priester, M. A., Browne, T., Iachini, A., Clone, S., DeHart, D., & Seay, K. D. (2016). Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: An integrative literature review. Journal of Substance Abuse Treatment, 61, 47–59. https://doi.org/10.1016/j.jsat.2015.09.006
   PubMed Web of Science ®Google Scholar
• Radfar, S. R., De Jong, C., Farhoudian, A., Ebrahimi, M., Rafei, P., Vahidi, M., Yunesian, M., Kouimtsidis, C., Arunogiri, S., Massah, O., Deylamizadeh, A., Brady, K. T., Busse, A., Potenza, M. N., Ekhtiari, H., & BaldAcchino, A. M., ISAM-PPIG Global Survey Consortium. (2021). Reorganization of substance use treatment and harm reduction services during the COVID-19 pandemic: A global survey. Frontiers in Psychiatry, 12, 639393. https://doi.org/10.3389/fpsyt.2021.639393
   PubMed Web of Science ®Google Scholar
• Saeed, S. A., & Masters, R. M. (2021). Disparities in health care and the digital divide. Current Psychiatry Reports, 23(9), 61. https://doi.org/10.1007/s11920-021-01274-4
   PubMed Web of Science ®Google Scholar
• Spivak, S., Spivak, A., Cullen, B., Meuchel, J., Johnston, D., Chernow, R., Green, C., & Mojtabai, R. (2020). Telepsychiatry use in U.S. mental health facilities, 2010-2017. Psychiatric Services (Washington, D.C.), 71(2), 121–127. https://doi.org/10.1176/appi.ps.201900261
   PubMed Web of Science ®Google Scholar
• Uhl, S., Bloschichak, A., Moran, A., McShea, K., Nunemaker, M. S., McKay, J. R., & D’Anci, K. E. (2022). Telehealth for substance use disorders: A rapid review for the 2021 U.S. Department of Veterans Affairs and U.S. Department of Defense guidelines for management of substance use disorders. Annals of Internal Medicine, 175(5), 691–700. https://doi.org/10.7326/M21-3931
   PubMed Web of Science ®Google Scholar
• Uscher-Pines, L., Cantor, J., Huskamp, H. A., Mehrotra, A., Busch, A., & Barnett, M. (2020). Adoption of telemedicine services by substance abuse treatment facilities in the U.S. Journal of Substance Abuse Treatment, 117, 108060. https://doi.org/10.1016/j.jsat.2020.108060
   PubMed Web of Science ®Google Scholar
• Vakkalanka, J. P., Lund, B. C., Ward, M. M., Arndt, S., Field, R. W., Charlton, M., & Carnahan, R. M. (2021). Telehealth utilization is associated with lower risk of discontinuation of buprenorphine: A retrospective cohort study of US veterans. Journal of General Internal Medicine, 37(7), 1610–1618. https://doi.org/10.1007/s11606-021-06969-1
   Google Scholar
• Volcy, J., Smith, W., Mills, K., Peterson, A., Kene-Ewulu, I., McNair, M., Kelsey, R., & Mbaezue, N. (2021). Assessment of patient and provider satisfaction with the change to telehealth from in-person visits at an academic safety net institution during the COVID-19 pandemic. Journal of the American Board of Family Medicine: JABFM, 34(Suppl), S71–S76. https://doi.org/10.3122/jabfm.2021.S1.200393
   PubMedGoogle Scholar